188 related articles for article (PubMed ID: 25053591)
1. Melittin enhances radiosensitivity of hypoxic head and neck squamous cell carcinoma by suppressing HIF-1α.
Yang X; Zhu H; Ge Y; Liu J; Cai J; Qin Q; Zhan L; Zhang C; Xu L; Liu Z; Yang Y; Yang Y; Ma J; Cheng H; Sun X
Tumour Biol; 2014 Oct; 35(10):10443-8. PubMed ID: 25053591
[TBL] [Abstract][Full Text] [Related]
2. Fenofibrate enhances radiosensitivity of esophageal squamous cell carcinoma by suppressing hypoxia-inducible factor-1α expression.
Ge Y; Liu J; Yang X; Zhu H; Yang B; Zhao K; Wu Z; Cheng G; Wang F; Ni F; Ge Q; Yang Y; Tai G; Sun X; Cai J
Tumour Biol; 2014 Nov; 35(11):10765-71. PubMed ID: 25073512
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
4. Targeting STAT3 inhibits growth and enhances radiosensitivity in head and neck squamous cell carcinoma.
Adachi M; Cui C; Dodge CT; Bhayani MK; Lai SY
Oral Oncol; 2012 Dec; 48(12):1220-6. PubMed ID: 22770899
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma.
Wu K; Mao YY; Chen Q; Zhang B; Zhang S; Wu HJ; Li Y
Cell Oncol (Dordr); 2021 Oct; 44(5):1167-1181. PubMed ID: 34460078
[TBL] [Abstract][Full Text] [Related]
6. 2-methoxyestradiol inhibits hypoxia-inducible factor 1alpha, tumor growth, and angiogenesis and augments paclitaxel efficacy in head and neck squamous cell carcinoma.
Ricker JL; Chen Z; Yang XP; Pribluda VS; Swartz GM; Van Waes C
Clin Cancer Res; 2004 Dec; 10(24):8665-73. PubMed ID: 15623651
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic induction of HIF-1alpha and VEGF expression in head and neck squamous cell carcinoma lines is mediated by stress activated protein kinases.
Shemirani B; Crowe DL
Oral Oncol; 2002 Apr; 38(3):251-7. PubMed ID: 11978547
[TBL] [Abstract][Full Text] [Related]
8. Melittin radiosensitizes esophageal squamous cell carcinoma with induction of apoptosis in vitro and in vivo.
Zhu H; Yang X; Liu J; Ge Y; Qin Q; Lu J; Zhan L; Liu Z; Zhang H; Chen X; Zhang C; Xu L; Cheng H; Sun X
Tumour Biol; 2014 Sep; 35(9):8699-705. PubMed ID: 24870598
[TBL] [Abstract][Full Text] [Related]
9. Nelfinavir down-regulates hypoxia-inducible factor 1alpha and VEGF expression and increases tumor oxygenation: implications for radiotherapy.
Pore N; Gupta AK; Cerniglia GJ; Jiang Z; Bernhard EJ; Evans SM; Koch CJ; Hahn SM; Maity A
Cancer Res; 2006 Sep; 66(18):9252-9. PubMed ID: 16982770
[TBL] [Abstract][Full Text] [Related]
10. BAY 87-2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts.
Helbig L; Koi L; Brüchner K; Gurtner K; Hess-Stumpp H; Unterschemmann K; Baumann M; Zips D; Yaromina A
Radiat Oncol; 2014 Sep; 9():207. PubMed ID: 25234922
[TBL] [Abstract][Full Text] [Related]
11. Activation of AKT by hypoxia: a potential target for hypoxic tumors of the head and neck.
Stegeman H; Kaanders JH; Wheeler DL; van der Kogel AJ; Verheijen MM; Waaijer SJ; Iida M; Grénman R; Span PN; Bussink J
BMC Cancer; 2012 Oct; 12():463. PubMed ID: 23046567
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma.
Sun ZJ; Yu GT; Huang CF; Bu LL; Liu JF; Ma SR; Zhang WF; Liu B; Zhang L
Oncotarget; 2016 Mar; 7(10):11651-63. PubMed ID: 26872381
[TBL] [Abstract][Full Text] [Related]
13. Berberine radiosensitizes human nasopharyngeal carcinoma by suppressing hypoxia-inducible factor-1α expression.
Zhang C; Yang X; Zhang Q; Yang B; Xu L; Qin Q; Zhu H; Liu J; Cai J; Tao G; Ma J; Ge X; Zhang S; Cheng H; Sun X
Acta Otolaryngol; 2014 Feb; 134(2):185-92. PubMed ID: 24325635
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1α and apoptosis proteins.
Wang D; Qin Q; Jiang QJ; Wang DF
J Xray Sci Technol; 2016 Apr; 24(4):639-46. PubMed ID: 27080362
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells.
Wiechec E; Hansson KT; Alexandersson L; Jönsson JI; Roberg K
Int J Mol Sci; 2017 Apr; 18(5):. PubMed ID: 28468237
[TBL] [Abstract][Full Text] [Related]
16. Overexpression and nuclear translocation of hypoxia-inducible factor prolyl hydroxylase PHD2 in head and neck squamous cell carcinoma is associated with tumor aggressiveness.
Jokilehto T; Rantanen K; Luukkaa M; Heikkinen P; Grenman R; Minn H; Kronqvist P; Jaakkola PM
Clin Cancer Res; 2006 Feb; 12(4):1080-7. PubMed ID: 16489060
[TBL] [Abstract][Full Text] [Related]
17. In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy.
Secades P; de Santa-María IS; Merlo A; Suarez C; Chiara MD
Head Neck; 2015 Aug; 37(8):1150-62. PubMed ID: 24798801
[TBL] [Abstract][Full Text] [Related]
18. Melittin inhibits the expression of key genes involved in tumor microenvironment formation by suppressing HIF-1α signaling in breast cancer cells.
Mir Hassani Z; Nabiuni M; Parivar K; Abdirad S; Karimzadeh L
Med Oncol; 2021 Jun; 38(7):77. PubMed ID: 34076777
[TBL] [Abstract][Full Text] [Related]
19. Blockade of adenosine A2A receptor enhances CD8
Ma SR; Deng WW; Liu JF; Mao L; Yu GT; Bu LL; Kulkarni AB; Zhang WF; Sun ZJ
Mol Cancer; 2017 Jun; 16(1):99. PubMed ID: 28592285
[TBL] [Abstract][Full Text] [Related]
20. Melittin suppresses HIF-1α/VEGF expression through inhibition of ERK and mTOR/p70S6K pathway in human cervical carcinoma cells.
Shin JM; Jeong YJ; Cho HJ; Park KK; Chung IK; Lee IK; Kwak JY; Chang HW; Kim CH; Moon SK; Kim WJ; Choi YH; Chang YC
PLoS One; 2013; 8(7):e69380. PubMed ID: 23936001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
